Connection

FIDA BACHA to Insulin

This is a "connection" page, showing publications FIDA BACHA has written about Insulin.
Connection Strength

3.390
  1. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
    View in: PubMed
    Score: 0.442
  2. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr. 2013 May; 162(5):924-9.
    View in: PubMed
    Score: 0.279
  3. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
    View in: PubMed
    Score: 0.262
  4. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care. 2009 Jan; 32(1):100-5.
    View in: PubMed
    Score: 0.208
  5. Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr. 2008 May; 152(5):618-21.
    View in: PubMed
    Score: 0.199
  6. Metabolic clearance rate of insulin across the glucose tolerance spectrum by race and ethnicity in youth with obesity. Obesity (Silver Spring). 2025 Jul; 33(7):1365-1374.
    View in: PubMed
    Score: 0.165
  7. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes. 2005 Jun; 6(2):100-2.
    View in: PubMed
    Score: 0.165
  8. Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
    View in: PubMed
    Score: 0.160
  9. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.123
  10. ?-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.
    View in: PubMed
    Score: 0.118
  11. Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
    View in: PubMed
    Score: 0.099
  12. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018; 89(1):47-55.
    View in: PubMed
    Score: 0.097
  13. Differences in ?-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role? Pediatr Diabetes. 2017 03; 18(2):143-151.
    View in: PubMed
    Score: 0.086
  14. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 01; 314(21):2241-50.
    View in: PubMed
    Score: 0.085
  15. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes. Pediatr Diabetes. 2016 12; 17(8):545-558.
    View in: PubMed
    Score: 0.085
  16. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov; 61(11):2787-95.
    View in: PubMed
    Score: 0.067
  17. Type 2 diabetes in youth: are there racial differences in ?-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes. 2012 May; 13(3):259-65.
    View in: PubMed
    Score: 0.064
  18. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
    View in: PubMed
    Score: 0.059
  19. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009 Mar; 58(3):738-44.
    View in: PubMed
    Score: 0.053
  20. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care. 2008 Jul; 31(7):1445-7.
    View in: PubMed
    Score: 0.050
  21. Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring). 2006 Sep; 14(9):1579-85.
    View in: PubMed
    Score: 0.045
  22. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care. 2006 Jul; 29(7):1599-604.
    View in: PubMed
    Score: 0.044
  23. Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab. 2006 Aug; 91(8):3117-22.
    View in: PubMed
    Score: 0.044
  24. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005 Jan; 28(1):115-9.
    View in: PubMed
    Score: 0.040
  25. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.036
  26. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003 Jun; 88(6):2534-40.
    View in: PubMed
    Score: 0.036
  27. Metabolic inflexibility in youth with obesity: Is it a feature of obesity or distinctive of youth who are metabolically unhealthy? Clin Obes. 2022 Apr; 12(2):e12501.
    View in: PubMed
    Score: 0.032
  28. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.032
  29. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
    View in: PubMed
    Score: 0.026
  30. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
    View in: PubMed
    Score: 0.026
  31. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.025
  32. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes Care. 2016 Aug; 39(8):1431-9.
    View in: PubMed
    Score: 0.022
  33. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care. 2013 Jul; 36(7):2048-53.
    View in: PubMed
    Score: 0.018
  34. Measuring ?-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? Diabetes Care. 2013 Jun; 36(6):1607-12.
    View in: PubMed
    Score: 0.017
  35. Metabolomic profiling of amino acids and ?-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
    View in: PubMed
    Score: 0.017
  36. ?-cell autoimmunity in overweight non-diabetic youth: any implications? Pediatr Diabetes. 2011 May; 12(3 Pt 2):207-11.
    View in: PubMed
    Score: 0.015
  37. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care. 2010 Mar; 33(3):632-8.
    View in: PubMed
    Score: 0.014
  38. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes. 2006 Oct; 7(5):260-6.
    View in: PubMed
    Score: 0.011
  39. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006 Feb; 148(2):188-94.
    View in: PubMed
    Score: 0.011
  40. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.